Showing results (61-70 of 69) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 69 results.
Scientific Reports|June 17, 2024
Comparison of juvenile and adult myasthenia gravis in a French cohort with focus on thymic histologyFrédérique Truffault, Ludivine Auger, Nadine Dragin, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|December 8, 2022
A new platform for autoimmune diseases. Inducing tolerance with liposomes encapsulating autoantigensLidia Almenara-Fuentes, Silvia Rodriguez-Fernandez, Estela Rosell-Mases, et al.
Journal of Autoimmunity|January 21, 2014
Clonal heterogeneity of thymic B cells from early-onset myasthenia gravis patients with antibodies against the acetylcholine receptorKathleen Vrolix, Judith Fraussen, Mario Losen, et al.
Journal of Autoimmunity|October 10, 2019
Risk factors associated with myasthenia gravis in thymoma patients: The potential role of thymic germinal centersClaire Mj Lefeuvre, Cloé A Payet, Odessa-Maud Fayet, et al.
Journal of Neuroimmunology|December 21, 2010
Reduced thymic expression of ErbB receptors without auto-antibodies against synaptic ErbB in myasthenia gravisKathleen Vrolix, Erik H Niks, Rozen Le Panse, et al.
Annals of Clinical and Translational Neurology|October 31, 2014
VAV1 and BAFF, via NFκB pathway, are genetic risk factors for myasthenia gravisNili Avidan, Rozen Le Panse, Hanne F Harbo, et al.
The Lancet Regional Health. Europe|February 3, 2025
Features of myositis and myasthenia gravis in patients treated with immune checkpoint inhibitors: a multicentric, retrospective cohort studyLotta Plomp, Hortense Chassepot, Dimitri Psimaras, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 31, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
High risk of hypoxemic COVID-19 pneumonia in myasthenia gravis patients with type I IFN autoantibodiesAdrian Gervais, Astrid Marchal, Alexis Maillard, et al.
Pageof 7